3136 results for «2675»

Filter By

3136 results

Enhancing clipping solutions for durable long-term patient outcomes

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...

Enhancing clipping solutions for durable long-term patient outcomes

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

20 May 2025 – From EuroPCR 2025

Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

How to build a tricuspid programme?

Challenging scenarios in patient with multivessel disease

20 May 2025 – From EuroPCR 2025

Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.

Challenging scenarios in patient with multivessel disease

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

21 May 2025 – From EuroPCR 2025

This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

DCB in de novo lesions: new valid option?

20 May 2025 – From EuroPCR 2025

Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.

DCB in de novo lesions: new valid option?

Challenging scenarios in acute coronary syndrome

20 May 2025 – From EuroPCR 2025

This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.

Challenging scenarios in acute coronary syndrome

Optimal management of high bleeding risk patient with multivessel disease

21 May 2025 – From EuroPCR 2025

This session offers a comprehensive overview of the management of high bleeding risk (HBR) patients with multivessel disease. Through expert discussion and a live case demonstration featuring a complex elderly patient, it highlights how intracoronary imaging and physiology can guide procedural decisions and improve outcomes in this...

Optimal management of high bleeding risk patient with multivessel disease

Optimising self-expandable TAVI clinical outcomes without compromise

22 May 2025 – From EuroPCR 2025

Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...

Optimising self-expandable TAVI clinical outcomes without compromise

TAVI - Procedural complications

20 May 2025 – From EuroPCR 2025

Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.

TAVI - Procedural complications

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

Primary PCI outside of the box: unusual STEMI cases

20 May 2025 – From EuroPCR 2025

This session presents unusual STEMI cases managed with primary PCI outside conventional protocols. Cases include heavily calcified lesions, STEMIs with non-flow-limiting stenoses, simultaneous occlusions with cardiac arrest, and other complex presentations, highlighting diverse interventional strategies.

Primary PCI outside of the box: unusual STEMI cases

RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer

20 May 2025 – From EuroPCR 2025

Discover how the next-generation RevoEdge high-pressure cutting balloon is transforming PCI with innovative design and proven clinical outcomes. This session presents a multicenter randomised trial and real-world case discussions, showcasing RevoEdge’s effectiveness in tackling resistant, complex lesions—including long, tortuous, and fibrotic cases. Learn practical tips, tricks,...

RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

22 May 2025 – From EuroPCR 2025

Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...

Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer

Ultrasound renal denervation is now guideline-recommended: how do I get started?

20 May 2025 – From EuroPCR 2025

Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...

Ultrasound renal denervation is now guideline-recommended: how do I get started?

Valve choice - Shaping index procedures and lifetime patient management

22 May 2025 – From EuroPCR 2025

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...

Valve choice - Shaping index procedures and lifetime patient management

TMVR in challenging scenarios

20 May 2025 – From EuroPCR 2025

Navigate the challenges of transcatheter mitral valve replacement (TMVR) in complex clinical scenarios. This session explores treatment options when clipping is not feasible in a patient with heart failure and severe MR, management of multivalvular disease, advanced septal crossing techniques, and strategies for non-surgical candidates ineligible...

TMVR in challenging scenarios

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

Why should laser atherectomy be part of your complex PCI algorithm?

21 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...

Why should laser atherectomy be part of your complex PCI algorithm?

Intracoronary imaging real world clinical cases

20 May 2025 – From EuroPCR 2025

Enhance your understanding of intracoronary imaging through real-world clinical cases demonstrating its critical role in complex coronary disease management. This session features cases involving physiological assessment, imaging-guided stent placement, and treatment planning for aneurysms and occlusions, highlighting the value of intravascular imaging in optimizing PCI outcomes.

Intracoronary imaging real world clinical cases
Didn’t find what you were looking for?